Cell Production Core
Cell Production Core
批准号:
8590752
负责人:
Bruce R Conklin
金额:
$18.18万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
未结题
起止时间:
2008-09-01 至
关键词:
Affinity ChromatographyBiochemicalBiologyBioreactorsCardiacCardiac MyocytesCell CountCell LineCellsComplexEmbryoEngineeringGoalsHeartHeart failureHumanInstructionKnowledgeLaboratoriesMass Spectrum AnalysisMolecularMusProductionProgram Research Project GrantsProteomicsProtocols documentationReagentResearch Project GrantsRunningSourceSuspension CultureSuspension substanceSuspensionsTissuescostembryonic stem cellflasksprogenitorresearch studyscale uptherapeutic target
中文摘要
为了实现这个PPG的目标,我们需要从小鼠中培养大量的心肌细胞(CM)。
胚胎干(ES)细胞来源,用于亲和纯化质谱(AP-MS)。CM生产将在
从6孔板扩大到大组织烧瓶,然后在生物反应器中悬浮培养。虽然
大规模的细胞生产在一个实验室中是低效的,将我们的努力结合到一个核心实验室中,
增加细胞产量,从而可以有效地实现AP-MS。
具体目标摘要
具体目标1:为计划研究项目提供高质量的细胞生产能力。
细胞生产核心将使研究项目能够生产大量的心脏祖细胞,
来源于工程小鼠ES细胞的CM。通过在悬浮液中扩增细胞,
生产水平至少比培养皿高两个数量级。这些细胞将
提供给蛋白质组学核心,以分析心脏分化的生化复合物。
具体目标2:为负担得起的大批量CM生产开发新的协议。
生物反应器已成功地用于在学术上生产大量的小鼠和人类CM。
和工业实验室,但主要的限制是试剂的成本。典型的生物反应器运行将使用
100升培养基和最先进的方案每次运行的成本可能超过80,000美元。我们将调整我们目前的
协议,使成本下降了70%以上,允许在大量的拟议实验,
细胞系
英文摘要
To achieve the goals of this PPG we will need to grow large quantities of cardiomyocytes (CMs) from mouse
embryonic stem (ES) cell sources, for affinity-purification mass spectrometry (AP-MS). CM production will be
scaled up from 6-well plates, to large tissue flasks and then suspension culture in a bioreactor. Although
large-scale cell production is inefficient in a single lab, combining our efforts into a core laboratory will
increase cell production so that the AP-MS can be achieved efficiently.
SPECIFIC AIMS SUMMARY
Specific Aim 1: To provide high-quality cell production capabilities for program research projects.
The cell production core will enable research projects to produce large quantities of cardiac progenitors and
CMs derived from engineered mouse ES cells. By expanding cells in suspension, we can attain cell
production levels that are at least two orders of magnitude greater than on petri dishes. These cells will be
provided to the Proteomics Core to analyze biochemical complexes that underlie cardiac differentiation.
Specific Aim 2: To develop new protocols for affordable high volume CM production.
Bioreactors have successfully been used to produce large amounts of mouse and human CMs in academic
and industrial laboratories, but the main limitation is the cost of reagents. Typical bioreactor runs will use
100 liters of media and state-of-the-art protocols can cost >$80,000 per run. We will adapt our current
protocols to bring the cost down by over 70%, allowing for the proposed experiments in a large numbers of
cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
-
批准号:10590420
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2021
-
负责人:Bruce R Conklin
-
依托单位:
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
-
批准号:10186371
-
项目类别:
-
资助金额:$212.63万
-
财政年份:2021
-
负责人:Bruce R Conklin
-
依托单位:
Core C: Genome Engineering Core
-
批准号:10245028
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2019
-
负责人:Bruce R Conklin
-
依托单位:
Core C: Genome Engineering Core
-
批准号:10471986
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2019
-
负责人:Bruce R Conklin
-
依托单位:
Core C: Genome Engineering Core
-
批准号:10006187
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2019
-
负责人:Bruce R Conklin
-
依托单位:
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
-
批准号:10249959
-
项目类别:
-
资助金额:$72.08万
-
财政年份:2018
-
负责人:Bruce R Conklin
-
依托单位:
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
-
批准号:10455604
-
项目类别:
-
资助金额:$72.08万
-
财政年份:2018
-
负责人:Bruce R Conklin
-
依托单位:
JAX-Gladstone, SCGE Disease Models Studies Supplement
-
批准号:10620067
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2018
-
负责人:Bruce R Conklin
-
依托单位:
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
-
批准号:9930312
-
项目类别:
-
资助金额:$4.41万
-
财政年份:2017
-
负责人:Bruce R Conklin
-
依托单位:
Therapeutic genome editing to treat Best disease
-
批准号:9980913
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2017
-
负责人:Bruce R Conklin
-
依托单位:
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
-
批准号:9384644
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2017
-
负责人:Bruce R Conklin
-
依托单位:
Therapeutic genome editing to treat Best disease
-
批准号:10200060
-
项目类别:
-
资助金额:$41.21万
-
财政年份:2017
-
负责人:Bruce R Conklin
-
依托单位:
Identifying Therapeutic Targets for RNA Splicing-Related Cardiomyopathy
-
批准号:9195146
-
项目类别:
-
资助金额:$45.65万
-
财政年份:2015
-
负责人:Bruce R Conklin
-
依托单位:
Disease Specific Cardiac Tissue Models
-
批准号:8138279
-
项目类别:
-
资助金额:$62.79万
-
财政年份:2011
-
负责人:Bruce R Conklin
-
依托单位:
Disease Specific Cardiac Tissue Models
-
批准号:8328586
-
项目类别:
-
资助金额:$61.65万
-
财政年份:2011
-
负责人:Bruce R Conklin
-
依托单位:
Disease Specific Cardiac Tissue Models
-
批准号:8676918
-
项目类别:
-
资助金额:$60.54万
-
财政年份:2011
-
负责人:Bruce R Conklin
-
依托单位:
Disease Specific Cardiac Tissue Models
-
批准号:8532967
-
项目类别:
-
资助金额:$57.74万
-
财政年份:2011
-
负责人:Bruce R Conklin
-
依托单位:
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)
-
批准号:8153362
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2010
-
负责人:Bruce R Conklin
-
依托单位:
Tissue Engineering with a Modular RASSL Toolbox
-
批准号:7822201
-
项目类别:
-
资助金额:$2.62万
-
财政年份:2009
-
负责人:Bruce R Conklin
-
依托单位:
GenMAPP-CS, a dynamic resource pathway analysis
-
批准号:7904722
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2009
-
负责人:Bruce R Conklin
-
依托单位:
海外基金